Axogen Inc vs Progressive Corp — how do they compare? Axogen Inc trades at $38.57 (market cap $2.06B), while Progressive Corp trades at $205.8 (market cap $131.91B). The key difference: Progressive Corp is far larger — about 64× Axogen Inc's market cap, and Progressive Corp pays a 6.13% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | PGR | |
|---|---|---|
Market Cap | $2.06B | $131.91B |
Sector | Technology | Financials |
52-Week High | $46.19 | $252.68 |
52-Week Low | $11.28 | $190.40 |
Enterprise Value | $1.98B | $140.14B |
Dividend Yield | — | 6.13% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Progressive (PGR) trades at $234.48, up 1.63% today, near its consensus price target of $240.89. The stock shows strong fundamentals with revenue growth from $49.6B in 2022 to $87.6B in 2025 and a net income margin of 12.93%. Technical indicators are bullish, with the price above key moving averages. Recent news highlights focus on Q2 2026 earnings expectations due July 15, 2026.
Outlook is positive given earnings growth and analyst buy ratings, but risks include potential earnings misses and competitive pressures. The stock offers value with a P/E of 11.93, below industry averages, supporting a bullish view for long-term investors despite near-term volatility.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →